日本癌学会

  Domestic

代議員   大阪産婦人科医会代議員会  

2022.04 - 2025.03 

査読委員   日本婦人科腫瘍学会  

2022.04 - 2025.03 

A difficult to diagnose case of low-grade endometrial stromal sarcoma with smooth muscle differentiation treated with laparoscopic surgery: A case report.

Ichimura T, Kasai M, Imai K, Yamauchi M, Fukuda T, Yasui T, Sumi T

Molecular and clinical oncology   16 ( 4 )   92   2022.04（ ISSN:2049-9450 ）

PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma.

Matsubara H, Fukuda T, Awazu Y, Nanno S, Shimomura M, Inoue Y, Yamauchi M, Yasui T, Sumi T

Oncology letters   21 ( 2 )   162   2021.02（ ISSN:1792-1074 ）

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer.

Shimomura M, Fukuda T, Awazu Y, Nanno S, Inoue Y, Matsubara H, Yamauchi M, Yasui T, Sumi T

Oncology letters   21 ( 2 )   150   2021.02（ ISSN:1792-1074 ）

A retrospective clinical analysis of 5 cases of vaginal melanoma.

Tasaka R, Fukuda T, Wada T, Kawanishi M, Imai K, Kasai M, Hashiguchi Y, Ichimura T, Yasui T, Sumi T

Molecular and clinical oncology   6 ( 3 )   373 - 376   2017.03（ ISSN:2049-9450 ）

Acceleration time of fetal arterial blood flow velocity waveforms: a preliminary study.

Osaka City Med J.   55 ( 1 )   29 - 34   2009

Uterine artery flow velocity waveforms during uterine contractions: differences between oxytocin-induced contractions and spontaneous labor contractions.

35 ( 5 )   850 - 4   2009

Estradiol-17beta regulates vascular endothelial growth factor and Bcl-2 expression in HHUA cells.

Int J Oncol.   31 ( 6 )   1333 - 8   2007

Expression of glucose transporters in epithelial ovarian carcinoma:correlation with clinical charactristics and tumor angiogenesis.

Oncl Rep.   Aug ( 18(2) )   361 - 367   2007

Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.

Int J Oncl   Sep ( 31(3) )   531 - 536   2007

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.

Int J Mol Med   Oct16 ( 4 )   541 - 6   2005（ ISBN:O ）

Expression of apoptosis-related proteins in advanced uterine cervical cancer after balloon-occluded arterial infusion chemotherapy as an indicator of the efficiency of this therapy.

Int J Mol Med   Jan15 ( 1 )   41 - 7   2005

Asymptomatic pelvic Castleman disease in an infertile woman: case report

Arch Gynecol Obstet   Jan269 ( 2 )   156 - 8   2004

Association of HPV infection with prognosis after neoadjuvant chemotherapy in advanced uterine cervical cancer

Int J Mol Med   Jul 14 ( 1 )   101 - 5   2004

The importance of studying pressure-flow for predicting postoperative voiding difficulties in women with stress urinary incontinence: a preliminary study that correlates low Pdet x Qave with postoperative residual urine.

Urol Res   May32 ( 2 )   84 - 8   2004

VEGF mRNA in adipocytes increase with rebound weight-gain after diet-restriction.

Int J Mol Med   Mar13 ( 3 )   395 - 9   2004

Disease associations and altered immune function in CD45 138G variant carriers.

Hum Mol Genet   Oct15 ( 13(20) )   2377 - 84   2004

A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression.

May 13 ( 100 )   5997 - 6002   2003

A high-frequency polymorphism in exson 6 of the CD45 tyrosine phosphatase gene(PTPRC)resulting in altered isoform expression

Proc Natl Acad Sci USA   100 ( 10 )   5997 - 6002   2003（ ISSN:0027-8424 ）

Expression of survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix

Oncol Rep.   10 ( 1 )   45 - 9   2003

Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder

Oncol Rep.   10 ( 2 )   345 - 9   2003

Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma

Oncol Rep.   10 ( 3 )   567 - 70   2003

Probucol decreases total body fat loss in VX2-carcinoma-induced cachectic rabbits

Oncol Rep.   8 ( 6 )   1309 - 11   2001

Balloon-occluded arterial infusion chemotherapy, simple total hysterectomy, and radiotherapy as a useful combination-therapy for advanced cancer of the uterine cervix

Oncol Rep.   7 ( 1 )   141 - 4   2000

Tumor marker and MR imaging criteria for evaluating the efficacy of cyclic balloon-occluded arterial infusion for advanced cancer of the uterine cervix

Oncol Rep.   7 ( 4 )   827 - 30   2000

Effects of cyclic plasma perfusion on adipocyte apoptosis and lipolytic activity in VX2 carcinoma-bearing rabbits

Anticancer Res.   20   827 - 830   2000

Metaboric and morphologic characteristics of adipose tissue assosiated with the growth of malignant tumors

Jpn J Cancer Res   90 ( 6 )   655 - 9   1999

Muscle cell apoptosis is responsible for the body weight loss in tumor-bearing rabbits

Osaka City Med J   45 ( 1 )   25 - 35   1999

Lipolitic activity of anemia-inducing substance from tumor-bearing rabbits

Nutr Cancer   33 ( 2 )   201 - 5   1999

Effects of plasmapheresis in a rabbit model of cancer cachexia

Osaka City Med J   44 ( 1 )   1 - 15   1998

Body composition analysis of cachectic rabbits by total body electrical conductivity

Nutri Cancer   32 ( 3 )   190 - 3   1998

TBX2発現は広汎子宮摘出術後にTPを補助化学療法として施行した中・高リスクのIB-IIB期子宮頸癌の再発と関連する(TBX2 expression is associated with recurrence of intermediate- and high-riskstage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP asadjuvant chemotherapy)

Noda Takuya, Fukuda Takeshi, Uchikura Eijiro, Awazu Yuichiro, Nanno Shigenori, Imai Kenji, Yamauchi Makoto, Yasui Tomoyo, Sumi Toshiyuki

日本産科婦人科学会雑誌  2023.02  (公社)日本産科婦人科学会

FYN発現は局所進行子宮頸癌に対する術後補助化学療法の有効性を予測する(FYN expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer)

Nanno Shigenori, Fukuda Takeshi, Noda Takuya, Uchikura Eijiro, Awazu Yuichir, Imai Kenji, Yamauchi Makoto, Yasui Tomoyo, Sumi Toshiyuki

The Journal of Obstetrics and Gynaecology Research  2023.01  John Wiley & Sons Australia, Ltd

CLPTM1L発現は、根治的子宮全摘術後に術後補助化学療法としてTP療法を施行された中・高リスクステージIB-IIB子宮頸癌の再発を予測する(CLPTMIL expression predicts recurrence of intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy)

Awazu Yuichiro, Fukuda Takeshi, Noda Takuya, Uchikura Eijiro, Nanno Shigenori, Imai Kenji, Yamauchi Makoto, Yasui Tomoyo, Sumi Toshiyuki

The Journal of Obstetrics and Gynaecology Research  2023.01  John Wiley & Sons Australia, Ltd

FYNの発現は局所進行子宮頸癌に対する主治療前化学療法の効果と関連する

南野 成則, 福田 武史, 内倉 慧二郎, 野田 拓也, 粟津 祐一朗, 今井 健至, 山内 真, 安井 智代, 角 俊幸

日本婦人科腫瘍学会学術講演会プログラム・抄録集  2022.07  (公社)日本婦人科腫瘍学会

CLPTM1Lの発現は術後補助療法としてTP療法を行った再発リスクを有する子宮頸癌の再発と関連する

粟津 祐一朗, 福田 武史, 内倉 慧二郎, 野田 拓也, 南野 成則, 今井 健至, 山内 真, 安井 智代, 角 俊幸

日本婦人科腫瘍学会学術講演会プログラム・抄録集  2022.07  (公社)日本婦人科腫瘍学会

FYN発現量からみた局所進行子宮頸癌に対するネオアジュバント化学療法の有効性の予測(FYN expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer)

Nanno Shigenori, Fukuda Takeshi, Noda Takuya, Uchikura Eijiro, Awazu Yuichiro, Imai Kenji, Yamauchi Makoto, Yasui Tomoyo, Sumi Toshiyuki

日本産科婦人科学会雑誌  2022.02  (公社)日本産科婦人科学会

FYN発現は局所進行子宮頸癌に対する術前補助化学療法の有効性を予測する(Expression of FYN predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer)

Nanno Shigenori, Yamauchi Makoto, Awazu Yuichiro, Kasai Mari, Fukuda Takeshi, Hashiguchi Yasunori, Ichimura Tomoyuki, Yasui Tomoyo, Sumi Toshiyuki

The Journal of Obstetrics and Gynaecology Research  2021.08  John Wiley & Sons Australia, Ltd

FYNの発現による局所進行子宮頸癌に対する主治療前化学療法の効果予測

南野 成則, 福田 武史, 内倉 慧二郎, 野田 拓也, 粟津 祐一朗, 今井 健至, 山内 真, 安井 智代, 角 俊幸

日本婦人科腫瘍学会学術講演会プログラム・抄録集  2021.07  (公社)日本婦人科腫瘍学会

FYN発現は局所進行子宮頸癌に対する術前補助化学療法の有効性を予測する(Expression of FYN predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer)

Nanno Shigenori, Yamauchi Makoto, Awazu Yuichiro, Kasai Mari, Fukuda Takeshi, Hashiguchi Yasunori, Ichimura Tomoyuki, Yasui Tomoyo, Sumi Toshiyuki

日本産科婦人科学会雑誌  2021.03  (公社)日本産科婦人科学会

PRMT1の発現は、漿液性卵巣癌に対するプラチナベースの化学療法に対する感受性と関連している

松原 裕明, 山内 真, 南野 成則, 井上 裕太, 下村 将央, 笠井 真理, 福田 武史, 橋口 裕紀, 市村 友季, 安井 智代, 角 俊幸

日本婦人科腫瘍学会雑誌  2021.01  (公社)日本婦人科腫瘍学会

PRMT1の発現による局所進行子宮頸癌に対する主治療前化学療法の効果予測

下村 将央, 山内 真, 南野 成則, 井上 裕太, 松原 裕明, 笠井 真理, 福田 武史, 橋口 裕紀, 市村 友季, 安井 智代, 角 俊幸

日本婦人科腫瘍学会雑誌  2021.01  (公社)日本婦人科腫瘍学会

PRMT1の発現からみた局所進行子宮頸癌に対する術前補助化学療法の有効性予測(Expression of PRMT1 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer)

Shimomura Masahiro, Yamauchi Makoto, Nanno Shigenori, Inoue Yuta, Matsubara Hiroaki, Kasai Mari, Fukuda Takeshi, Hashiguchi Yasunori, Ichimura Tomoyuki, Yasui Tomoyo, Sumi Toshiyuki

The Journal of Obstetrics and Gynaecology Research  2020.08  John Wiley & Sons Australia, Ltd

PRMT1発現と卵巣漿液性癌のプラチナベース化学療法に対する感受性との関連(Expression of PRMT1 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma)

Matsubara Hiroaki, Yamauchi Makoto, Nanno Shigenori, Shimomura Masahiro, Inoue Yuta, Kasai Mari, Fukuda Takeshi, Hashiguchi Yasunori, Ichimura Tomoyuki, Yasui Tomoyo, Sumi Toshiyuki

The Journal of Obstetrics and Gynaecology Research  2020.08  John Wiley & Sons Australia, Ltd

TBX2の発現からみた局所進行子宮頸癌に対する術前補助化学療法の有効性予測(Expression of TBX2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer)

Inoue Yuta, Yamauchi Makoto, Nanno Shigenori, Shimomura Masahiro, Matsubara Hiroaki, Kasai Mari, Fukuda Takeshi, Hashiguchi Yasunori, Ichimura Tomoyuki, Yasui Tomoyo, Sumi Toshiyuki

The Journal of Obstetrics and Gynaecology Research  2020.08  John Wiley & Sons Australia, Ltd

PRMT1発現と卵巣漿液性癌のプラチナベース化学療法に対する感受性との関連性(Expression of PRMT1 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma)

Matsubara Hiroaki, Yamauchi Makoto, Nanno Shigenori, Shimomura Masahiro, Inoue Yuta, Kasai Mari, Fukuda Takeshi, Hashiguchi Yasunori, Ichimura Tomoyuki, Yasui Tomoyo, Sumi Toshiyuki

日本産科婦人科学会雑誌  2020.03  (公社)日本産科婦人科学会